Walleye Trading’s Achieve Life Sciences ACHV Stock Holding History

Walleye Trading’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,086	Closed	-$68K	–	4541
2018 Q3	$68K	Buy	+1,086	New	+$68.7K	﹤0.01%	4412

Other funds holding ACHV

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Walleye Trading's ACHV Position: Q4 2018 in Review

Walleye Trading sold out of Achieve Life Sciences (ACHV) in Q4 2018, closing a stake of 1,086 shares — an estimated $68K sold.

Walleye Trading first reported a position in ACHV in Q3 2018 and held it in 1 quarter. The position peaked at $68K in Q3 2018. 11 funds tracked by Wall St. Rank hold ACHV as of Q4 2018.

Walleye Trading reported no remaining Achieve Life Sciences position as of Q4 2018 after selling out during the quarter.
Walleye Trading sold 1,086 Achieve Life Sciences shares in Q4 2018, an estimated $68K.
Walleye Trading first reported a position in Achieve Life Sciences in Q3 2018 and held it in 1 quarter.
Walleye Trading's Achieve Life Sciences position peaked at $68K in Q3 2018.
11 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2018.

Based on Walleye Trading's 13F filing for Q4 2018, filed 14 Feb 2019.